WisdomTree BioRevolution Fund (WDNA): Price and Financial Metrics ETF
WDNA Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $14.58 | 52-week high | $17.96 |
| Prev. close | $14.38 | 52-week low | $14.31 |
| Day low | $14.31 | Volume | 400 |
| Day high | $14.60 | Avg. volume | 928 |
| 50-day MA | $15.69 | Dividend yield | N/A |
| 200-day MA | $16.14 |
WDNA Stock Price Chart Interactive Chart >
WisdomTree BioRevolution Fund (WDNA) ETF Bio
The WisdomTree BioRevolution Fund seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index. The WisdomTree BioRevolution Index is designed to track performance of companies that will be significantly transformed by advancements in genetics and biotechnology that meet Index eligibility requirements. The Index was established with a base value of 200 on April 30, 2021.
WDNA ETF Info
| Issuer | |
| Expense Ratio | % |
| Asset Class | |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | N/A |
| Net Asset Value (NAV) | $0.00 |
| Options? | No |
| Total Holdings | 95 |
WDNA Top Holdings
| Symbol | Company | % of Total |
| NTRA | Natera Inc | 4.03% |
| BPMC | Blueprint Medicines Corp | 2.52% |
| VERA | Veracyte Inc | 2.43% |
| LLY | Eli Lilly & Co | 2.29% |
| AGIO | Agios Pharmaceuticals Inc | 2.05% |
| BBIO | Bridgebio Pharma Inc | 1.9% |
WDNA Price Returns
| 1-mo | -5.16% |
| 3-mo | -11.39% |
| 6-mo | -8.87% |
| 1-year | -13.65% |
| 3-year | -38.82% |
| 5-year | N/A |
| YTD | -13.54% |
| 2023 | -2.07% |
| 2022 | -26.29% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |